BMY

Decoding BMY's Earnings Track Record

Bristol-Myers Squibb (BMY) has beaten earnings estimates in all eight of its last reported quarters, a 100% beat rate, with an average earnings surprise of 17.2%, according to GammaQC earnings intelligence as of 2026-08-03. That consistency includes the July 30, 2026 print, when actual EPS of $2.04 came in $0.44 above the $1.60 estimate, a 27.5% surprise. Other recent beats were the April 30, 2026 report at $1.58 versus $1.42 (11.3% surprise), the February 5, 2026 report at $1.26 versus $1.23 (2.4% surprise), and the October 30, 2025 report at $1.63 versus $1.52 (7.2% surprise).

Yet beating estimates has not translated into sustained post-report upside. Across the last eight quarters, the average 5-day price move after earnings was -1.46%, classified as a “down” drift. Recent individual 5-day moves include 0.00% after the July 30, 2026 report, -7.16% after the April 30, 2026 report, +0.57% after the February 5, 2026 report, and +2.21% after the October 30, 2025 report. That gap between a 100% beat rate and a negative average drift is the central tension for traders: the bar for beating may already be reflected in the price, or the market’s real expectation may simply be higher than the published consensus.

Options-Flow Dynamics Before the October 29 Report

With BMY scheduled to report next on October 29, 2026, before the open and with consensus EPS at $1.70, options markets are likely pricing an earnings move that incorporates the stock’s history of beats. As traders position for the release, implied volatility typically rises into the event, inflating the cost of near-dated options. A stock showing an RSI of 67.6 and trading at $64.92—already above a 50-day EMA of $59.45—means the options surface may also reflect momentum premium within the Healthcare/Drug Manufacturers - General sector.

Pricing models and flow activity around such a release can create asymmetry even if the earnings outcome itself mirrors the 100% beat rate. For example, the July 30, 2026 report beat by 27.5% yet produced only a 0.69% next-day move and 0.00% five-day drift; the April 30, 2026 report beat by 11.3% yet the stock fell 3.91% the next day and 7.16% over the following five days. Those reactions suggest that post-earnings options structures—short gamma after the event or volatility sellers unwinding positions—can dominate directional follow-through.

What a Disciplined Trader Watches

A disciplined approach treats the 100% beat rate and the -1.46% average five-day drift as two distinct data points, not a single signal. Traders can watch whether the October 29, 2026 report causes a gap above or below the $59.45 50-day EMA, whether RSI above 60 holds into the close following the print, and whether volume confirms the size of the move relative to the prior four releases.

They can also compare the implied move priced into options against the historical realized moves—next-day reactions of 0.69%, -3.91%, 4.15%, and 0.99%, and five-day drifts of 0.00%, -7.16%, 0.57%, and +2.21%. If the options market is pricing a move near the larger end of that range but the fundamental setup resembles quarters with muted post-report follow-through, the discrepancy itself becomes the watch item. Risk management matters because a beat is not the same thing as a rally.

For a deeper dive into how institutional models, options flow, and analyst revisions are positioning around BMY ahead of the October 29, 2026 report, explore the full institutional verdict on the ticker page.